Skip to content
Loading
French
Spanish
Chinese
Japanese
Korean

Industry Sectors

Medical, Biotechnology & Pharmaceutical

Ridout & Maybee LLP provides a full spectrum of intellectual property services in the fields of life sciences, biotechnology, and the pharmaceutical fields.

Our professionals utilize their industry and legal experience to provide advice and assistance to clients worldwide and have degrees and decades of experience in the fields of chemistry, chemical engineering, molecular biology and genetics, nanotechnology engineering, medical and health physics, cellular and molecular medicine, biomedical engineering, biomechanics, biochemistry, biology, medical devices, life sciences, plant agriculture and more.

We represent top Canadian and international medical and pharmaceutical clients, from start-ups to Fortune 100 companies, as well as universities, government agencies, and industrial associations.

Our firm’s sector experience includes the fields of:

Have a question for a professional in any of our medical, biotechnology or pharmaceutical groups? See which members of our team can help you get started.

Our People

Kazim Agha

Patent Agent - Partner

Toronto

Charles Boulakia

Lawyer, Patent & Trademark Agent - Partner

Toronto

Mitchell Charness

Lawyer, Patent & Trademark Agent - Partner*

Ottawa

Giselle Chin

Lawyer, Patent & Trademark Agent - Associate

Burlington

Meika Ellis

Lawyer - Associate

Ottawa

Gerald Gowan

Patent & Trademark Agent - Counsel

Burlington

David Greer

Lawyer, Patent & Trademark Agent - Partner*

Toronto

David Heller

Lawyer, Patent & Trademark Agent - Partner*

Toronto

Roland Joachim

Lawyer, Patent & Trademark Agent - Partner*

Toronto

Ken Ma

Lawyer, Patent Agent - Associate

Ottawa

Benjamin Mak

Lawyer, Patent & Trademark Agent - Partner

Toronto

Matthew Norwood

Lawyer, Patent Agent - Partner

Toronto

Dan Raymond

Patent Agent - Associate

Ottawa

Christine Wong

Patent Agent - Partner

Toronto

Recent IP & Firm News

Paracetamol Capsules

CETA: Pharma Patent Changes Coming on September 21, 2017

Canada’s Comprehensive Economic and Trade Agreement (CETA) with the European Union and its Member States heralds significant reform to many of Canada’s IP laws.

Read News Item

pills and drugs

Much ado about nothing? Pharmaceuticals and the Trans-Pacific Partnership Agreement in Canada

On October 5, 2015, 12 countries including Canada signed the final draft of the Trans-Pacific Partnership Agreement (“TPP”).

Read News Item